Analyze Diet

Topic:Pharmacokinetics

Pharmacokinetics in horses involves the study of how drugs are absorbed, distributed, metabolized, and excreted in equine species. This field of study provides insights into the time course of drug concentrations within the horse's body and helps in understanding the effects of various pharmaceuticals. Key parameters in equine pharmacokinetics include absorption rates, bioavailability, half-life, and clearance. These parameters can vary significantly due to factors such as age, breed, and health status of the horse. This page compiles peer-reviewed research studies and scholarly articles that explore the pharmacokinetic profiles of different drugs in horses, aiming to optimize dosing regimens and improve therapeutic outcomes in equine medicine.
Clinical trial to determine the effect of omeprazole given once or twice daily on gastric ulceration.
Equine veterinary journal. Supplement    March 4, 2000   Issue 29 87-90 doi: 10.1111/j.2042-3306.1999.tb05177.x
Vatistas NJ, Nieto JE, Snyder JR, Thompson D.No abstract available
Efficacy of omeprazole paste in the treatment and prevention of gastric ulcers in horses.
Equine veterinary journal. Supplement    March 4, 2000   Issue 29 81-86 doi: 10.1111/j.2042-3306.1999.tb05176.x
Andrews FM, Sifferman RL, Bernard W, Hughes FE, Holste JE, Daurio CP, Alva R, Cox JL.Equine gastric ulcer syndrome (EGUS) is very common among performance horses, with a reported prevalence of approximately 90% in racehorses, and also > 50% in foals. Omeprazole, an acid pump inhibitor 5 times more potent than ranitidine, has been used with great success to treat EGUS. This multicentre study of Thoroughbred racehorses with endoscopically verified gastric ulcers was designed to demonstrate the efficacy of an equine oral paste formulation of omeprazole in the treatment and prevention of recurrence of EGUS. Of the 100 horses entered into the study, 25 were sham-dosed for the full ...
Acceptability of a paste formulation and efficacy of high dose omeprazole in healing gastric ulcers in horses maintained in race training.
Equine veterinary journal. Supplement    March 4, 2000   Issue 29 71-76 doi: 10.1111/j.2042-3306.1999.tb05174.x
Vatistas NJ, Snyder JR, Nieto J, Thompson D, Pollmeier M, Holste J.Gastric ulceration has been found to occur in 80-90% of Thoroughbreds in active race training. Previously, variable success has been reported using mucosal surface protectants and H2 receptor antagonist. Omeprazole, a substituted benzimidazole, has been shown to inhibit gastric acid secretion in both man and animals. Fourteen horses, in active race training and with endoscopic evidence of moderated to severe gastric ulceration were divided into 2 groups: Group 1 (7 horses) were given placebo paste orally once daily for 28 days; Group 2 (7 horses) received 1.54 g active omeprazole in the placeb...
Safety of omeprazole paste in foals and mature horses.
Equine veterinary journal. Supplement    March 4, 2000   Issue 29 63-66 doi: 10.1111/j.2042-3306.1999.tb05172.x
Plue RE, Wall HG, Daurio C, Attebery DK, Cox JL, Wallace DH.Omeprazole has been shown to promote healing of spontaneously occurring gastric ulcers in horses when administered for 28 days at a dose of 4 mg/kg bwt/day and to prevent recurrence of ulcers in almost all horses when treatment is continued at a dose of at least 2 mg/kg bwt/day. The purpose of the 3 studies reported here was to 1) evaluate the evolution of potential effects of omeprazole paste (GastroGard), at a dose of 20 mg/kg bwt/day (5x the recommended dose) for 91 days in mature Thoroughbred horses; 2) evaluate the safety in young horses of omeprazole paste when dosed at 4 mg/kg bwt/day (...
Effect of omeprazole paste on gastric acid secretion in horses.
Equine veterinary journal. Supplement    March 4, 2000   Issue 29 59-62 doi: 10.1111/j.2042-3306.1999.tb05171.x
Daurio CP, Holste JE, Andrews FM, Merritt AM, Blackford JT, Dolz F, Thompson DR.In a multicentre trial, 13 cannulated horses were treated orally once daily with a paste that delivered omeprazole at a dose of 4 and 5 mg/kg bwt in a 2-period crossover design to evaluate steady state gastric acid suppression. In each period, basal (unstimulated) and pentagastrin-stimulated gastric output were evaluated at 5-8 h after 5 doses, at 13-16 h after 10 doses, and at 21-24 h after 15 doses. Baseline data for gastric acid secretion were collected once for each horse in the month prior to initiation of omeprazole treatment. The inhibition of gastric acid secretion relative to baseline...
Comparison of the antisecretory effects of omeprazole when administered intravenously, as acid-stable granules and as an oral paste in horses.
Equine veterinary journal. Supplement    March 4, 2000   Issue 29 54-58 doi: 10.1111/j.2042-3306.1999.tb05170.x
Haven ML, Dave K, Burrow JA, Merritt AM, Harris D, Zhang D, Hickey GJ.The antisecretory activity of omeprazole on gastric acid when administered i.v., intragastrically or per os, was evaluated in 2 female and 3 castrated male horses. Each horse had been prepared with a chronic indwelling gastric cannula. A single i.v. administration of omeprazole (1.5 mg/kg bwt) was effective in abolishing basal and pentagastrin (PG)-stimulated acid secretion. Once daily, nasogastric administration of omeprazole in acid-stable granules for 5 days inhibited acid secretion in a dose-dependent manner: 57% (1.5 mg/kg bwt) and 98% (5.0 mg/kg bwt) reduction of PG-stimulated acid secre...
Effects of intramuscular omeprazole on gastric acid secretion in horses over a twenty-four hour period.
Equine veterinary journal. Supplement    March 4, 2000   Issue 29 50-53 doi: 10.1111/j.2042-3306.1999.tb05169.x
Sandin A, Andrews FM, Nadeau JA, Doherty TJ, Nilsson G.The effect of intramuscular (i.m.) omeprazole (0.25 or 1.0 mg/kg bwt; LD and HD), respectively, on volume, total acid output (TAO) and pH of the gastric juice was studied during 24 h in 5 horses with a chronically implanted gastric cannula. Whether secretion in controls was basal or stimulated with pentagastrin (8 micrograms/kg bwt/h), volume (NS) and TAO (P < 0.01, NS) gradually decreased and pH increased (P < 0.05, NS). Omeprazole significantly reduced the average basal TAO by 49 +/- 6% (LD) and 88 +/- 3% (HD) and the stimulated TAO by 64 +/- 2% and 97 +/- 1%. Basal pH in controls was 2.1-4....
Effects of frusemide on electrolyte and acid-base balance during exercise.
Equine veterinary journal. Supplement    February 5, 2000   Issue 30 370-374 doi: 10.1111/j.2042-3306.1999.tb05250.x
Carlson GP, Jones JH.This study was undertaken to evaluate the effects of frusemide on the concentration of plasma electrolytes and the relationship between changes in electrolyte concentration and the simultaneous changes in acid-base balance in arterial and venous blood during intense exercise. Five exercise-conditioned Thoroughbred horses were exercised on a high-speed treadmill at a slope of 10% at speeds known to exceed VO2max. Horses participated in 3 randomised exercise trials in which they received either placebo (control), low-dose frusemide (0.5 mg/kg bwt), or high-dose frusemide (1.0 mg/kg) 4 h prior to...
Sedation and antisedation as tools in equine lameness examination.
Equine veterinary journal. Supplement    February 5, 2000   Issue 30 227-230 doi: 10.1111/j.2042-3306.1999.tb05223.x
Buchner HH, Kübber P, Zohmann E, Peham C.A kinematic study was performed to establish the locomotion pattern of horses under detomidine sedation and the effects of antagonization for possible use during lameness examinations in uncooperative horses. The kinematics of 17 Warmblood horses (9 sound, 8 lame with chronic forelimb lameness) were recorded on 2 days using a high-speed video system while trotting (3.9 m/s) on a treadmill. On each day a control measurement was carried out prior to sedation with detomidine (10 micrograms/kg bwt) and repeated recordings at 15, 25, 35, 45 and 60 min after sedation. On the second day, sedation was...
Effects of frusemide on pulmonary capillary pressure in horses exercising on a treadmill.
Equine veterinary journal. Supplement    February 5, 2000   Issue 30 102-106 doi: 10.1111/j.2042-3306.1999.tb05198.x
Gleed FD, Ducharme NG, Hackett RP, Hakim TS, Erb HN, Mitchell LM, Soderholm LV.We hypothesised that frusemide would decrease pulmonary capillary pressure in horses during strenuous exercise. Seven horses were tested after receiving saline or frusemide (2 mg/kg bwt) in random order with an interval of at least one week. Measurements were made with the horses standing, exercising at 75, 90 and 100% HRmax (maximal heart rate), and then walking 2 min after cessation of 100% HRmax. The exercise tests lasted for approximately 3 min with an interval of walking between them. Pulmonary artery and oesophageal pressures were recorded continuously and subsequent analysis of the pulm...
Repeated administration of frusemide does not offer an advantage over single dosing in attenuating exercise-induced pulmonary hypertension in thoroughbred horses.
Equine veterinary journal. Supplement    February 5, 2000   Issue 30 539-545 doi: 10.1111/j.2042-3306.1999.tb05280.x
Goetz TE, Manohar M, Magid JH.The objective of the present study was to ascertain whether administration of a second dose of frusemide would attenuate exercise-induced pulmonary hypertension more than a single dose. Right atrial, right ventricular and pulmonary vascular pressures were determined in 7 healthy, sound, exercise-trained Thoroughbred horses at rest and during exercise (14.2 m/s + a 3.5% uphill grade) performed at maximal heart rate (217 +/- 3 beats/min [mean +/- s.e.]). Horses were studied during the following 3 treatments in random order 7 days apart: control (no medication), frusemide single dose (250 mg i.v....
Diclazuril in the horse: its identification and detection and preliminary pharmacokinetics.
Journal of veterinary pharmacology and therapeutics    January 29, 2000   Volume 22, Issue 6 374-379 doi: 10.1046/j.1365-2885.1999.00232.x
Dirikolu L, Lehner F, Nattrass C, Bentz BG, Woods WE, Carter WG, Karpiesiuk W, Jacobs J, Boyles J, Harkins JD, Granstrom DE, Tobin T.Diclazuril (4-chlorophenyl [2,6-dichloro-4-(4,5-dihydro-3H-3,5-dioxo-1,2,4-triazin-2-yl)pheny l] acetonitrile), is a benzeneacetonitrile antiprotozoal agent (Janssen Research Compound R 64433) marketed as Clinacox . Diclazuril may have clinical application in the treatment of Equine Protozoal Myeloencephalitis (EPM). To evaluate its bioavailability and preliminary pharmacokinetics in the horse we developed a sensitive quantitative high-pressure liquid chromatography (HPLC) method for diclazuril in equine biological fluids. MS/MS analysis of diclazuril in our HPLC solvent yielded mass spectral ...
Use of right ventricular pressure increase rate to evaluate cardiac contractility in horses.
American journal of veterinary research    January 6, 2000   Volume 60, Issue 12 1508-1512 
Nollet H, Van Loon G, Deprez P, Sustronck B, Muylle E.To establish reference values for right ventricular maximal rate of increase in pressure (dP/dt(max)) in horses and determine the usefulness of this variable to evaluate cardiac contractility. Methods: 15 crossbred horses, 3 to 20 years old. Methods: Cardiac catheterization was performed, using a high-fidelity catheter tip micromanometer, to determine right ventricular dP/dt(max). The following mathematic corrections were made: for preload, (dP/dt(max))/instantaneous total pressure, (dP/dt(max))/instantaneous developed pressure, and (dP/dt(max))/end diastolic pressure; for afterload, (dP/dtCPI...
The confirmation and control of metabolic caffeine in standardbred horses after administration of theophylline.
Journal of veterinary pharmacology and therapeutics    December 22, 1999   Volume 22, Issue 5 333-342 doi: 10.1046/j.1365-2885.1999.00226.x
Todi F, Mendonca M, Ryan M, Herskovits P.The origin of caffeine detections in equine serum and urine after theophylline administrations was examined. Three different preparations containing theophylline were administered to standardbred mares. Both blood and urine samples were collected. Caffeine was detected and quantified in theophylline administration samples by high performance liquid chromatography (HPLC) and liquid chromatography-tandem mass spectrometry (LC-MS-MS). Further in vitro analysis showed that caffeine metabolites were not detected when caffeine, or caffeine-containing products, were added to urine. Data derived from ...
Methadone screening of racehorses.
Journal of analytical toxicology    December 14, 1999   Volume 23, Issue 7 609-614 doi: 10.1093/jat/23.7.609
Hagedorn HW, Meiser H, Zankl H, Schulz R.The misuse of opiates in racehorses relates to their effect of increasing locomotor activity. Because methadone, a narcotic analgesic, has been suspected of use as a doping compound in the past, it was added to the list of banned drugs and should be considered in doping control. Because the literature fails to provide information on detection of methadone in blood or urine of horses, an enzyme-linked immunosorbent assay was developed to monitor this narcotic in equine body fluids. Combined with high-performance liquid chromatography, the immunoassay also served to confirm positives indicated b...
Clinical pharmacology of nervous system diseases.
The Veterinary clinics of North America. Equine practice    December 10, 1999   Volume 15, Issue 3 575-588 doi: 10.1016/s0749-0739(17)30133-5
Dowling PM.The well-developed defense barriers of the CNS and the expense of drug therapy limit the pharmacologic options for the treatment of neurologic diseases in horses. New approaches to controlling inflammation in the CNS are improving the outcomes of bacterial meningitis. The appropriate treatment of EPM remains controversial. More research is needed to evaluate the pharmacokinetics and pharmacodynamics of drugs in the CNS of the horse. Behavioral pharmacology has become fashionable in human and small animal medicine, but it needs to be evaluated for the potential of unethical use in performance h...
Formulary of common equine drugs.
The Veterinary clinics of North America. Equine practice    December 10, 1999   Volume 15, Issue 3 747-xi doi: 10.1016/s0749-0739(17)30142-6
Whittem T.This article presents in easily accessible form a collection of drug names and dose rates for the drugs recommended or referred to by the authors of the individual articles in this issue. Although the formulary provides recommendations for drug use, the reader is cautioned that the responsibility for the choice of agent, formulation, dose, and dose interval lies with the clinician. The author also addresses regulations that govern the use of drugs in competition horses.
Equine cardiac disease. Clinical pharmacology and therapeutics.
The Veterinary clinics of North America. Equine practice    December 10, 1999   Volume 15, Issue 3 523-vii doi: 10.1016/s0749-0739(17)30130-x
Mogg TD.Cardiac disease is often life-threatening and challenging to treat. Prolonged therapy is indicated in many cases, which can lead to problems with treatment costs, owner compliance, and potential drug toxicity. Many therapies are empirical or based on data from other species because of a lack of well-designed prospective clinical trials in horses. This article reviews the clinical pharmacology and therapeutics of heart failure, cardiac arrhythmias, myocardial disease, endocarditis, and pericardial disease.
Pharmacologic considerations in the treatment of neonatal septicemia and its complications.
The Veterinary clinics of North America. Equine practice    December 10, 1999   Volume 15, Issue 3 725-746 doi: 10.1016/s0749-0739(17)30141-4
Wichtel ME, Buys E, DeLuca J, Stringel G.This article focuses on the pharmacologic properties of drugs commonly used in the treatment of neonatal septicemia and its complications. Rational therapy demands an awareness of not only the pharmacology of individual drugs but also the interactions and anticipated fate of such drugs in the rapidly changing physiologic environment of the neonate. Further research in the area of equine neonatal pharmacology should greatly assist our understanding of the impact of the disease state on the unique physiology of the newborn and should allow us to better predict the ultimate fate of drugs commonly...
Renal pharmacology.
The Veterinary clinics of North America. Equine practice    December 10, 1999   Volume 15, Issue 3 647-ix doi: 10.1016/s0749-0739(17)30137-2
Jose-Cunilleras E, Hinchcliff KW.Pharmacologic treatment of diseases of the urinary tract of horses is limited to administration of antibiotics for treatment of urinary tract infections (UTIs), administration of drugs that alter urine pH, administration of drugs that alter bladder smooth muscle function or urethral sphincter tone, and treatment of acute renal failure. The indications, mechanisms of action, pharmacokinetic characteristics, and adverse effects of these agents in each of these groups are discussed in this article. The use of the agents is discussed within the context of the pathophysiology of the disease being t...
Modes of local drug delivery to the musculoskeletal system.
The Veterinary clinics of North America. Equine practice    December 10, 1999   Volume 15, Issue 3 603-622 doi: 10.1016/s0749-0739(17)30135-9
Anderson BH, Ethell MT.A number of methods for the local delivery of drugs to musculoskeletal tissues in the horse are now available. Further research is required to document the disposition of drugs delivered by such methods and to correlate this information with efficacy. Perhaps the greatest potential area for the methods discussed is the treatment of synovial and bone infections. To be able to provide high and sustained therapeutic concentrations of antimicrobials to the site of infection should increase the chances of success in such cases. These methods of drug delivery need to be used in conjunction with othe...
Pharmacokinetics of flunixin meglumine in donkeys, mules, and horses.
American journal of veterinary research    November 24, 1999   Volume 60, Issue 11 1441-1444 
Coakley M, Peck KE, Taylor TS, Matthews NS, Mealey KL.To compare serum disposition of flunixin meglumine after i.v. administration of a bolus to horses, donkeys, and mules. Methods: 3 clinically normal horses, 5 clinically normal donkeys, and 5 clinically normal mules. Methods: Blood samples were collected at time zero (before) and 5, 10, 15, 30, and 45 minutes, and at 1, 1.25, 1.5, 1.75, 2, 2.5, 2.75, 3, 3.5, 4, 4.5, 5, 5.5, 6, and 8 hours after i.v. administration of a bolus of flunixin meglumine (1.1 mg/kg of body weight). Serum was analyzed in duplicate by the use of high-performance liquid chromatography for determination of flunixin meglumi...
Pharmacokinetic interactions between flunixin and sulphadimidine in horses.
DTW. Deutsche tierarztliche Wochenschrift    November 5, 1999   Volume 106, Issue 9 400-403 
el-Banna HA.The pharmacokinetic aspects of sulphadimidine were studied in clinically healthy (control) and Flunixin-medicated horses after a single intravenous and oral administration of 100 mg/kg body weight. Plasma sulphadimidine concentration were determined by high-performance liquid chromatography (HPLC). Following the intravenous injection, all plasma sulphadimidine data were best approximated by a two-compartment open model using sequential, weight non-linear regression. Flunixin induced a 67% increase in the rate of sulphadimidine return to the central compartment from peripheral tissues (K21) and...
MR 20492 and MR 20494: two indolizinone derivatives that strongly inhibit human aromatase.
The Journal of steroid biochemistry and molecular biology    October 21, 1999   Volume 70, Issue 1-3 59-71 doi: 10.1016/s0960-0760(99)00093-x
Auvray P, Sourdaine P, Moslemi S, Séralini GE, Sonnet P, Enguehard C, Guillon J, Dallemagne P, Bureau R, Rault S.In this study, we describe the synthesis of a new family of indolizinone derivatives designed to fit an extrahydrophobic pocket within the active site of aromatase and to strongly inhibit human aromatase. This could help improve the specificity of the inhibitors. Equine aromatase, very well characterized biochemically, is used as a comparative model. Indeed, in a previous comparison between both human and equine aromatases, we described the importance of the interaction between the inhibitor and this pocket for the indane derivative MR 20814. MR 20492 and MR 20494 are more potent inhibitors of...
Disposition and tolerance of suxibuzone in horses.
Equine veterinary journal    October 3, 1999   Volume 31, Issue 5 411-416 doi: 10.1111/j.2042-3306.1999.tb03841.x
Jaraiz MV, Rodriguez C, San Andres MD, Gonzalez F, San Andres MI.Suxibuzone (SBZ), a nonsteroidal anti-inflammatory drug, was administered to 6 horses at a dose rate of 7.5 mg/kg bwt by intravenous (i.v.) route. Plasma and synovial fluid concentrations of suxibuzone and its main active metabolites, phenylbutazone (PBZ) and oxyphenbutazone (OPBZ), were measured simultaneously by a sensitive and specific high-performance liquid chromatographic method. The pharmacokinetic parameters were determined by noncompartmental analysis. Plasma SBZ concentrations rapidly decreased and were not detectable beyond 20 min after treatment. The parent drug was not detected in...
Bioavailability of racemic ketoprofen in healthy horses following rectal administration.
Research in veterinary science    September 30, 1999   Volume 67, Issue 2 203-204 doi: 10.1053/rvsc.1999.0303
Corveleyn S, Henrist D, Remon JP, Van Der Weken G, Baeyens W, Haustraete J, Aboul-Enein HY, Sustronck B, Deprez P.Ketoprofen (KTP) is a chiral non-steroidal anti-inflammatory drug (NSAID) of the propionic acid class, approved by the FDA for the allevation of pain associated with musculoskeletal disorders in horses. The present study was designed to examine the bioavailability of ketoprofen enantiomers after rectal administration of the racemate to healthy horses. One gram of racemic ketoprofen was injected intravenously and administered rectally as a fat based suppository in a cross-over design study (n = 4). Blood samples were analysed for KTP enantiomers using HPLC. After IV administration, the S(+) ena...
Pharmacokinetics and bioequivalence of two suxibuzone oral dosage forms in horses.
Journal of veterinary pharmacology and therapeutics    September 28, 1999   Volume 22, Issue 4 247-254 doi: 10.1046/j.1365-2885.1999.00219.x
Jaraiz V, Rodriguez C, San Andres MD, Gonzalez F, San Andres MI.A disposition and bioequivalence study with a suxibuzone granulated and a suxibuzone paste oral formulation was performed in horses. Suxibuzone (SBZ) is a nonsteroidal anti-inflammatory drug, which was administered to horses (n = 6) at a dosage of 19 mg/kg bwt by the oral route (p.o.) in a two period cross-over design. Suxibuzone is very rapidly transformed into its main active metabolites, phenylbutazone (PBZ) and oxyphenbutazone (OPBZ). Therefore plasma and synovial fluid concentrations of SBZ, PBZ and OPBZ were simultaneously measured by a sensitive and specific high-performance liquid chro...
The effect of sedation on gastric emptying of a liquid marker in ponies.
Veterinary surgery : VS    September 24, 1999   Volume 28, Issue 5 375-379 doi: 10.1111/j.1532-950x.1999.00375.x
Doherty TJ, Andrews FM, Provenza MK, Frazier DL.The effect of sedation on gastric emptying was evaluated in six ponies by monitoring serum concentrations of acetaminophen (AP) after intragastric administration. Methods: Prospective randomized experimental study. Methods: Six adult ponies, 135 to 275 kg. Methods: Fifteen minutes after the intravenous administration of xylazine (1 mg/kg), butorphanol (0.05 mg/kg), acepromazine (0.05 mg/kg) or saline, ponies were given AP (20 mg/kg in 350 mL water) by stomach tube. Blood for AP analysis was collected at baseline and 15, 30, 45, 75, 90, 105, and 120 minutes after AP administration. The time (Tm...
Pharmacokinetics of ibuprofen after intravenous and oral administration and assessment of safety of administration to healthy foals.
American journal of veterinary research    September 18, 1999   Volume 60, Issue 9 1066-1073 
Breuhaus BA, DeGraves FJ, Honore EK, Papich MG.To determine pharmacokinetics of ibuprofen in healthy foals and to determine clinical effects after oral administration for 6 days. Methods: 7 healthy 5- to 10-week-old foals. Methods: Serum concentrations of ibuprofen were measured after IV and oral (nasogastric tube) administration at dosages of 10 and 25 mg/kg of body weight. Foals were given ibuprofen (25 mg/kg, PO, q 8 h) as a paste for 6 days. Serum and urine were obtained before and after the 6-day period. Results: Half-life of elimination (Kel t1/2) of IV-administered ibuprofen (ie, 10 and 25 mg/kg), was 79 and 108 minutes, maximal ser...
Detection and identification of flunixin after multiple intravenous and intramuscular doses to horses.
Journal of analytical toxicology    September 17, 1999   Volume 23, Issue 5 372-379 doi: 10.1093/jat/23.5.372
Sams RA, Gerken DF, Ashcraft SM.The objectives of the study were to compare various methods to determine flunixin in test samples collected periodically from horses after intramuscular (IM) and intravenous (IV) dosing at the maximum recommended dosage and to document detection times for this drug in test samples. Flunixin, a nonsteroidal anti-inflammatory drug approved for use in horses, was administered to eight mares in five consecutive daily doses of 1.1 mg per kilogram of body weight by the IM or IV route. Flunixin was detected in urine samples collected at various times after drug administration by flunixin enzyme-linke...
1 53 54 55 56 57 97